UBC Medical Indonesia Tbk. vs Penta Valent Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Penta Valent Tbk. trades at Rp310 (market cap 547.34B, 520.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. and Penta Valent Tbk. are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 520.2K). Which is the better fit depends on your goals.
| LABS | PEVE | |
|---|---|---|
Market Cap | 576.7B | 547.34B |
Volume | 3.48M | 520.2K |
Lot | 34.82K | 5.2K |
Turnover | 522.79M | 161.08M |
Average Price | 150.13 | 309.65 |
Value | 522.79M | 161.08M |
Indicative Equilibrium Price | 148 | — |
Indicative Equilibrium Volume | 350 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →